Doxorubicin as an unusual cause of organizing pneumonia
Keywords:
Cryptogenic organizing pneumonia, Drug-Related side effects and Adverse Reactions, DoxorubicinAbstract
Organizing pneumonia is a syndrome that is characterized by respiratory illness that can be severe and life threatening. There are several well-well known causes of organizing pneumonia, including infections, environmental exposures and drugs. More specifically, there are several chemotherapeutic agents that are associated with organizing pneumonia. In addition, a very common cause is exposure to radiation in the context of radiation therapy in the treatment of breast cancer. However, in the presented case, a female with breast cancer was treated with doxorubicin in the absence of radiation therapy and developed organizing pneumonia. The cause was thought to be secondary to doxorubicin. Previously, there has only been one reported case of organizing pneumonia secondary to doxorubicin. This poses the question that perhaps drug induced organizing pneumonia, specifically secondary to chemotherapeutic agents, is more common than previously reported and the association with radiation therapy may be overestimated.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.